Israeli biotech company NextFerm has partnered with Soft Gel Technologies (Commerce, CA) to release a new, exclusive-grade Astaferm astaxanthin, which is designed specifically for softgel applications and will be offered as ready-to-use softgels.
 
In 2019, NextFerm introduced a new, natural astaxanthin product—made via yeast fermentation—called Astaferm. Further announcement included the release of a special grade for gummies and the patenting of this product, which covers aspects of composition and efficacy.
 
“We’re very excited about the way the market is responding to our new approach and messaging, and the backing of a reputable contract manufacturer in Soft Gel means a lot to us. The addition of a softgel application to our previous launch of gummies adds yet another important segment to our marketing efforts and our reach,” said Elzaphan Hotam, CEO of NextFerm USA.
 
“For us, we see a great opportunity to introduce a new and fresh approach to what was a completely generic and stagnant market until recently. Astaferm is a non-GMO, sustainable and non-marine-sourced astaxanthin. This is a natural and effective product, which offers brands a simple way to differentiate themselves at a competitive price and without compromising on the highest quality standards,” said Steve Holtby, president and CEO of Soft Gel Technologies, Inc.
 
“We will start promoting this product via our sales and marketing channels and during the coming Expo West show,” Holtby added.